Neurogenomics
A section of Genes (ISSN 2073-4425).
Section Information
The section “Neurogenomics” publishes papers of broad interest and significance covering all aspects of brain genetics and genomics immediately relevant to a broad audience of those interested in genetics. This section focuses on recent advances in genomics and genetics research related to the diagnosis, treatment, and prognosis of neurological disorders, in addition to neurodevelopment and pathogenic mechanisms.
Topics within the scope of this section include, but are not limited to, the following:
- Multi-omics studies on neurological function and development;
- Functional genomics approaches in neurological diseases;
- The genetics of neurological monogenic diseases and complex disorders;
- Genetic testing and molecular diagnostics of neurological diseases;
- Genotype–phenotype correlations;
- Precision medicine;
- Pharmacogenetics and pharmacogenomics;
- Advanced therapies (gene therapy/ targeted genome editing/genetically engineered cell therapy/RNA- and small nucleic acid-based therapeutics) for neurological diseases.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Mechanisms and Therapeutics in Autism: From Genes to Clinical Practice (Deadline: 20 September 2026)
- Feature Papers in "Neurogenetics and Neurogenomics": 2026 (Deadline: 25 December 2026)
- Genetic Regulation of Neurons and Behavioral Genetics (Deadline: 15 March 2027)
- Genetic Research of Neurodevelopmental Disorders (Deadline: 10 July 2027)